UBE2C promotes cell cycle progression and suppresses DNA damage-induced apoptosis in triple-negative breast cancer
{{output}}
Background: Triple-negative breast cancer (TNBC), characterized by its aggressiveness, constitutes a unique breast cancer subtype, lacking effective targeted therapies. Its progression is often driven by cell cycle control dysfun... ...
